Olerup SSP extends its product portfolio through a new exclusive sales agreement

LinkMed’s transplantation company, Olerup SSP, has signed an exclusive sales agreement with the American company Biotium for their product GelRed™. The sales agreements gives Olerup SSP the exclusive rights to sell GelRed™ to the HLA typing market. GelRed™ is an environmentally safe and ultrasensitive fluorescent nucleic acid gel stains designed to replace the highly toxic ethidium bromide (EtBr).Developed by Biotium, GelRed™ is superior to EtBr and other EtBr alternatives by having a combination of low toxicity, high sensitivity and exceptional stability. GelRed™ is a sensitive, stable and